Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001181431-10-010942

Options or other derivatives

  • SVP & GENERAL COUNSEL acquired 6,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ozeroff Christopher David · SVP & GENERAL COUNSEL

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2010-02-18 Grant or award : show line 1 in the form Option to Purchase Common Stock +6,400 $2.97 2020-02-18 6,400 6,400 D
Loading xslF345X03/rrd266113.xml…